1-Benzyl-3-formyl-1H-indole-5-carbonitrile

Catalog No.: 
ACZKXP816
CAS No.: 
1360583-74-9
Molecular Formula: 
C17H12N2O
Molecular Weight: 
260.30
1-Benzyl-3-formyl-1H-indole-5-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$231.00In stockInquiry
250mg95%$385.00In stockInquiry
500mg95%$552.00In stockInquiry
1g95%$824.00In stockInquiry
5g95%$2472.00InquiryInquiry
10g95%$4128.00InquiryInquiry
25g95%$8257.00InquiryInquiry
50g95%$13209.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Benzyl-3-formyl-1H-indole-5-carbonitrile
IUPAC Name1-benzyl-3-formyl-1H-indole-5-carbonitrile
Molecular FormulaC17H12N2O
Molecular Weight260.30
SMILESN#CC1=CC2=C(N(CC3=CC=CC=C3)C=C2C=O)C=C1
InChI KeyDUPSZBHQYYQCDA-UHFFFAOYSA-N
Synonym1H-Indole-5-carbonitrile, 3-formyl-1-(phenylmethyl)-
CAS No.1360583-74-9

Synthetic Route by SureRoute

1. ACZKXP816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVCDR521 route compound structure diagram
    ACVCDR52117380-18-6In Stock
  4. Then
  5. ACZKXP816 route product structure diagram
    ACZKXP8161360583-74-9In Stock
Inquiry

2. ACZKXP816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMWUN215 route compound structure diagram
    ACMWUN21580531-13-1In Stock
  4. Then
  5. ACZKXP816 route product structure diagram
    ACZKXP8161360583-74-9In Stock
Inquiry

3. ACZKXP816 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVCDR521 route compound structure diagram
    ACVCDR52117380-18-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZKXP816 route product structure diagram
    ACZKXP8161360583-74-9In Stock
Inquiry

Comments (0)